Rudnay M, Hrabčáková P, Lazúrová I
I. Interná Klinika Lekárskej Fakulty UPJS a UNL. Pasteura Kosice, Slovenská Republika, Prednostka prof. MUDr. Ivica Lazúrová, CSc.
Vnitr Lek. 2012 Jan;58(1):52-5.
Hyponatremia is the most common electrolyte imbalance in outpatients and hospital inpatients and the syndrom of inappropriate secretion of antidiuretic hormone (SIADH) is one of the common causes of euvolemic hyponatremia. Recent studies showed significantly higher mortality and morbidity of hyponatriemic patients compared to normonatriemic controls. Moreover the morbidity and mortality of hyponatremic patients significantly increases in nontreated in comparison to those with the therapy. Clinical consequences of hyponatremia in SIADH could be devided according to stage of the disorder. The cerebral oedema with its symptoms (letargy, weakness, nausea, coma) is the most dangerous clinical feature. Clinical symptoms of hyponatremia also depend on how rapid the change of natremia is. Therefore the early diagnosis of disturbance and treatment are necessary. Not only acute but also chronic hyponatriemia must be treated. In the correction the restriction of water intake, loop diuretics (together with hypertonic solution of NaCl), demeclocyclin, urea and litium can be used. The blockers of vasopresin receptors - vaptans are perspective in treatment of patients with hyponatremia.
低钠血症是门诊患者和住院患者中最常见的电解质紊乱,抗利尿激素分泌不当综合征(SIADH)是等容量性低钠血症的常见原因之一。最近的研究表明,与血钠正常的对照组相比,低钠血症患者的死亡率和发病率显著更高。此外,与接受治疗的患者相比,未经治疗的低钠血症患者的发病率和死亡率显著增加。SIADH中低钠血症的临床后果可根据疾病阶段进行划分。伴有症状(嗜睡、虚弱、恶心、昏迷)的脑水肿是最危险的临床特征。低钠血症的临床症状还取决于血钠变化的速度。因此,早期诊断紊乱并进行治疗是必要的。不仅急性低钠血症,慢性低钠血症也必须治疗。在纠正过程中,可使用限制水摄入、袢利尿剂(与高渗氯化钠溶液合用)、地美环素、尿素和锂。血管加压素受体阻滞剂——托伐普坦在低钠血症患者的治疗中具有前景。